Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
The American Society for Clinical Pathology (ASCP), in collaboration with Pfizer and with participation from the American Society of Clinical Oncology (ASCO), announced a Request for Proposals (RFP) ...
Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...
A biomarker blood panel that incorporates four different proteins-ANPEP, PIGR, CA19-9, and THBS2-enhanced the detection of pancreatic ductal ...
As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.
A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2 ...
Alzheimer’s disease (AD) is characterized by the accumulation of neurofibrillary tangles in the brain, composed of hyperphosphorylated tau, and amyloid plaques, consisting of distinct β-amyloid ...
Immunotherapy, targeted treatments, HIPEC, and new delivery options ...
VO₂ Max — the maximum amount of oxygen the body can use during exercise — is recognized by the American Heart Association as ...